Foghorn Therapeutics Inc. · NASDAQ:FHTX
BVF PARTNERS L P/IL reported a 9.99% stake in Foghorn Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
BVF PARTNERS L P/IL reported a 9.99% stake in Foghorn Therapeutics Inc., 5,866,613 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 5,866,613
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.40% | 3,164,410 |
| BVF I GP LLC | 5.40% | 3,164,410 |
| BIOTECHNOLOGY VALUE FUND II LP | 3.80% | 2,218,382 |
| BVF II GP LLC | 3.80% | 2,218,382 |
| Biotechnology Value Trading Fund OS LP | 0.70% | 402,467 |
| BVF Partners OS Ltd. | 0.70% | 402,467 |
| BVF GP HOLDINGS LLC | 9.20% | 5,382,792 |
| BVF PARTNERS L P/IL | 9.99% | 5,866,613 |
| BVF INC/IL | 9.99% | 5,866,613 |
| LAMPERT MARK N | 9.99% | 5,866,613 |
Source
Related
- Foghorn Therapeutics Inc.
- Bvf Partners L P
- Foghorn Therapeutics Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Oct 5, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Form 4 · Gottschalk Adrian · Apr 13, 2026
- Schedule 13D/A · Flagship Ventures Fund V, L.P. · Jan 13, 2026
- Schedule 13G/A · FMR LLC · Feb 12, 2025